According to reports from The Economic Times, Natco Pharma is currently trading above the neckline of a rounding bottom formation on daily charts. This technical pattern suggests a potential bullish outlook for the pharmaceutical company. The stock is part of the pharma space and is engaged in research and development, manufacturing and selling of bulk drugs, and finished dosage forms.
As reported by The Economic Times, experts are recommending medium-term traders to consider buying the stock for a possible target of ₹1,240 in the next 2-3 months. The recommendation is based on the strong buying conviction observed in the current technical setup and the potential trend change after a year of consolidation period. The analysis suggests that the rounding bottom formation pattern indicates a potential trend reversal for Natco Pharma.
According to the analysis reported by The Economic Times, the rounding bottom formation pattern indicates a potential trend reversal for Natco Pharma. The stock's position above the neckline suggests improved technical strength and could signal a shift from the previous consolidation phase. The target price of ₹1,240 represents a significant upside potential from current levels, with experts citing strong buying conviction as the key driver for this bullish outlook.
